Deadly Diarrhea Caused by Co-Infection of Clostridium perfringens Type ST-865 and Clostridium difficile: A Case Report and Review of the Literature
Abstract
Purpose There is a paucity of evidence regarding the occurrence of fatalities resulting from diarrhea due to co-infection with C. perfringens and C. difficile. Here, we report a rare case of severe diarrhea caused by a novel ST-865 type of C. perfringens in conjunction with C. difficile to draw the attention of clinicians and microbiology laboratory staff. Case Descriptions The patient is male, 69 years old and one month before admission, there was diarrhea without fever. The doctor administered anti-infective treatments such as levofloxacin, ceftriaxone, minocycline, gentamicin and tinidazole, and sent fecal samples for anaerobic culture. Two colonies, Clostridium perfringens and Clostridium difficile, were cultivated and identified by sequencing as type F-Clostridium perfringens of ST-865 and Clostridium difficile carrying toxins A and B. Conclusion The case we reported, which involved a severe case of diarrhea caused by a combined infection of ST-865 type F-type Clostridium perfringens and Clostridium difficile carrying both A and B toxins, and resulting in eventual death, is extremely rare. Such cases should draw the attention of clinicians and microbiology laboratory personnel.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.